BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 248 filers reported holding BLUEPRINT MEDICINES CORP in Q1 2022. The put-call ratio across all filers is 0.59 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $255,505 | +146.1% | 2,770 | +34.0% | 0.01% | +133.3% |
| Q3 2023 | $103,805 | -32.6% | 2,067 | -15.2% | 0.00% | -25.0% |
| Q2 2023 | $154,082 | -67.4% | 2,438 | -73.9% | 0.00% | -71.4% |
| Q2 2022 | $472,000 | +564.8% | 9,348 | +1314.2% | 0.01% | +1300.0% |
| Q4 2021 | $71,000 | +57.8% | 661 | +51.6% | 0.00% | 0.0% |
| Q3 2021 | $45,000 | +60.7% | 436 | +38.4% | 0.00% | 0.0% |
| Q2 2021 | $28,000 | -95.9% | 315 | -94.8% | 0.00% | -96.8% |
| Q4 2020 | $675,000 | -13.8% | 6,016 | -28.8% | 0.03% | -29.5% |
| Q3 2020 | $783,000 | – | 8,444 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
| CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
| Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
| DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
| Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
| Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
| Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
| Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
| EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
| Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |